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Background: One problem that conventional ascending treatment for type A aortic
dissection has not satisfactorily resolved is chronic enlargement of residual dissec-
tion in the aortic arch and descending aorta. To address this problem, we have
developed a new method for type A aortic dissection: total arch graft implantation
with open-style stent-graft placement.
Methods: From October 1994 through October 1999, 19 patients with type A aortic
dissection (13 acute and 6 chronic dissections) underwent total arch graft implan-
tation with open-style stent-graft placement. After achievement of general anesthe-
sia and hypothermic extracorporeal circulation, we replaced the dissected ascending
aorta and neck vessels with a 4-branched graft and repaired the descending aorta
with a stent graft to close the entry site completely and to obtain better peripheral
perfusion. We then examined the acute-phase and chronic-phase results and the
outcomes of the false lumen and dissected aorta.
Results: There were 1 (5.3%) hospital death and 2 late deaths. The survivals at 1 and
3 years were 89.5% and 82.6%, respectively. The following complications occurred
in the perioperative period: 1 stroke, 2 cases of temporary paraparesis, 2 cases of
temporary hemodialysis, and 3 cases of mediastinitis. No pulmonary complications
were observed. Six months postoperatively, the targeted entry sites were completely
closed in all cases, 80% (8/10) of preoperatively patent false lumina were clotted at
the level of the end of the stent graft, and 60% (9/15) of the false lumina and 40%
(6/15) of the dissected aorta had shrunk significantly. Two (13.3%) of 15 cases of
postoperative dilatation in the dissected aorta were observed, and reoperation related
to residual dissected aorta was performed in only 1 (1/17 [5.9%]) patient during the
mean follow-up period of 2.4  1.6 years.
Conclusion: Our preliminary review of the total arch graft implantation with a stent
graft suggests that this new procedure for type A aortic dissection might provide
better results in both the acute and the chronic phase, especially with regard to the
outcome for the false lumen and dissected aorta.
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Conventional surgical treatment for proxi-mal aortic dissection (ie, type A aortic dis-section) is graft replacement or resection ofthe entry site in the ascending aorta toprevent intrapericardial rupture.1-4 How-ever, because this surgical treatment has
improved the life prognosis for the acute phase in recent
years,5-9 the discussion has been changing from the acute-
phase mortality rate to postoperative morbidity and the
prognosis of residual dissection in the chronic phase.10-16
The shift has been prompted by relatively high late mortal-
ity7,10-12 and experience with reoperation for enlargement of
residual dissection in the aortic arch and descending aorta
after the conventional operation to repair the ascending
aorta.11-16
Therefore for patients with type A aortic dissection who
are forecast to have enlargement of residual dissection with
only conventional ascending treatment, such as patients
who are young (60 years), have Marfan syndrome, or
have residual entry in the arch or descending aorta,11,12,14,16
we have introduced a method in which we implant the stent
graft in the descending aorta from the surgically opened
aortic arch simultaneously with graft replacement of the
ascending aorta and the aortic arch.17,18 The purpose is to
avoid enlargement of the residual dissected aorta and diffi-
cult reoperations in the chronic phase. This new method is
intended to obtain clotting formation and shrinkage of the
false lumen by having the stent graft ensure entry-site
closure in the aortic arch or descending aorta and continu-
ous compression on the false lumen.
We evaluated the results of our procedure in terms of
mortality and morbidity in the acute phase, late survival,
and the outcome for the false lumen and dissected aorta in
patients with type A aortic dissection.
Methods
Patients
From October 1994 through October 1999, 19 patients (11 men
and 8 women) with type A aortic dissection underwent open-style
stent-graft implantation after approval of the procedure by the
hospital ethics committee of Osaka Prefectural Hospital. We ob-
tained informed consent in each case. The average age of the
patients was 59.7  12.5 years (range, 41-78 years). Thirteen
(68%) were in the acute stage (within 2 weeks from the onset of
dissection), and 6 had chronic dissection (ie, 4 patients with
chronic dissection were treated within 2 months of onset, and the
date of onset was unclear in 2 patients). Emergency surgery was
performed in the 13 patients whose onset of symptoms was within
48 hours before arrival at the hospital or who had rupture, cardiac
tamponade, or both. Four of the 19 patients had a previous cerebral
accident, 1 had atypical angina pectoris, 1 had a greater than 75%
coronary artery stenosis in a major branch, and 2 had congestive
heart failure with severe aortic regurgitation. One patient had
chronic renal failure and had received a renal transplant 2 months
earlier. Previous aortic operations had been performed in 3 pa-
tients: 2 for abdominal aortic aneurysm and 1 for thoracoabdomi-
nal aneurysm. There were 2 patients with suspected Marfan syn-
drome.
The 19 patients were selected for total arch graft implantation
with open stent-graft placement because the entry site was located
in the aortic arch or descending aorta and they had an enlarged
aortic arch or descending aorta (40 mm in aortic diameter), neck
vessel dissection (in patients 60 years), or Marfan syndrome.
The entry site was detected only in the ascending aorta in 3
patients, the ascending aorta and arch or descending aorta in 3
patients, and the arch or descending aorta in 13 patients. The
locations of these entry sites were ascertained by means of aor-
tography, transesophageal echocardiography, and direct intraoper-
ative diagnosis. Dilatation of the aortic arch or descending aorta
was seen in 3 patients. Neck vessel dissections were also observed
in 12 patients and 23 arteries. In association with aortic dissection,
3 had a neurologic disorder, 3 had cardiac tamponade with shock,
1 had respiratory dysfunction, 3 had leg ischemia, and 2 had
suspected intestinal ischemia. The clinical characteristics of the 19
patients are shown in Table 1.
During the same 5-year period, 25 patients with type A dissec-
tion who were excluded from the foregoing indications (19 acute
and 6 chronic dissections) underwent the conventional surgical
procedure (graft replacement of the ascending aorta or the ascend-
ing aorta with proximal arch). No surgical deaths, 2 cerebral
complications, 3 respiratory complications, 2 episodes of hemodi-
alysis, and 1 episode of mediastinitis were observed in this con-
ventional surgical operation.
Imaging Protocol
All 19 patients underwent chest radiography and spiral computed
tomographic scanning, and 17 underwent aortography or digital
subtraction angiography before the surgical procedure. The true
luminal diameter (D) of the descending aorta was calculated from
the planimetered circumference (Cf) of the true lumen measured
by means of enhanced computed tomographic scanning as follows:
D  Cf/pi.
Description of the Device
The surgical stent graft (Figure 1, A and B) was composed of a
stainless-steel Z-shaped stent and polyester graft material. The
triple tandem-type Gianturco stent (William Cook Europe A/S)
was inserted in the distal part of a noncoated polyester fabric graft
(Toray Medicals or Inter Vascular, Inc) with the crimp ironed out.
These polyester grafts are usually used as the implanting graft in
conventional thoracic and abdominal aortic aneurysm surgery. The
stent was attached to the graft with a series of interrupted 5-0
polypropylene sutures. The device was described in detail in a
previous study.17
For each patient, the diameter selected for the polyester graft
was 100% to 120% of the diameter of the true lumen at the
intended distal level of the dissected portion. The diameter of the
Gianturco stent was proportional to that of the polyester graft: A
40-mm-diameter stent was selected for a 28-mm or larger graft,
and a 30-mm-diameter stent was selected for a 26-mm or smaller
graft.
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Procedure
All procedures are performed with the patients under general
anesthesia sustained by means of endotracheal intubation and
mechanical ventilation. A Swan-Ganz catheter, left radial and
unilateral temporal arterial line, and probe for transesophageal
echocardiographic monitoring are inserted.
The patient is placed in a supine position, and median sternot-
omy is the surgical approach. Systemic heparinization (300 U/kg)
is initiated before vessel cannulation. The arterial return cannula is
placed in the right axillary artery. The femoral artery is also
cannulated from the bifurcated arterial return line (Figure 2, A).
Bicaval venous cannulas are usually inserted through the right
atrium. Cardiopulmonary bypass is initiated, and flow rates are
maintained between 2.4 and 2.8 L  min1  m2.
During core cooling to a bladder temperature of 24°C, the
ascending aorta is clamped with a Fogarty clamp, and cold crys-
talloid cardioplegic solution is injected retrogradely to achieve
cardiac arrest. A collagen- or gelatin-coated woven Dacron graft
with 4 branches is sutured to the ascending aorta in the usual
manner, with 3-0 polypropylene sutures (Figure 2, B). After prox-
imal anastomosis has been completed in the ascending aorta,
bypass anastomoses from the 4-branch graft to the left subclavian
artery and left carotid artery are performed, and the perfusion for
these cervical branches is restarted from the 4-branch graft,
through which the return cannula has been inserted (Figure 2, B).
Perfusion to the lower body is discontinued when the brachioce-
phalic artery is perfused through the right axillary return cannula
and left carotid artery, left subclavian artery, and coronary arteries
through the 4-branch graft at around 1000 mL  min1  m2
(Figure 2, B and C).
The aortic arch is transected at the predetermined proximal
anastomotic line (between the brachiocephalic artery and the left
carotid artery). During transesophageal echocardiographic moni-
toring, a 30F catheter sheath (Figure 1, C) that has been curved to
correspond to the aortic arch for the individual patient and has been
loaded with the stent graft is inserted through the proximal incision
site to the intended distal attachment portion (ie, to the point at which
tight contact between the stent graft and vascular wall is possible over
TABLE 1. Pre-operative characteristics of 19 patients
Patient Sex Age (y)
Acute(A) or
chronic(C)
Past history//
preoperative condition
Position of
primary entry
Dilation in arch
or descending
aorta
Dissection of
cervical artery
Position of abdominal
re-entry
1 F 45 C HT, CRF, s/p renal transplant // NS Ascending, arch N Y Between SMA and
IMA, aortic
bifurcation
2 F 66 A HT, cerebral bleeding // shock with
tamponade, coronary dissection
Descending N N ()
3 F 67 C HT, AR // NS Ascending Y N ()
4 M 72 A HT, s/p graft replacement for AAA,
OCI // LOC
Ascending, arch N Y Celiac artery
5 M 64 A AAE, AR, Marfan // CHF Descending N Y Intercostal artery,
Left RA
6 M 42 C HT, HL // NS Descending N N Left RA, Intercostal
and lumbar artery
7 M 41 A HT, AAE, IHD // shock with
tamponade, intubated, ischemia
in lower body
Arch N Y Proximal of celiac
artery, Right RA
8 M 47 A Marfan // ischemia in bilateral legs Descending N N Celiac artery
9 F 75 A HT, s/p graft replacement for AAA,
atypical angina // NS
Ascending Y N ()
10 M 70 A HT, DM, OCI // LOC Descending N Y ()
11 F 62 A HT, s/p graft replacement for TAbA
// LOC, shock with tamponade
Ascending Y Y ()
12 M 65 A HT, DM, rectal cancer, ileus // NS Arch N Y Unknown
13 F 54 A HT, DM // NS Arch N Y Right RA
14 M 66 C HT // cardiac tamponade Arch N Y ()
15 F 78 A HT // NS Arch N Y Unknown
16 F 76 A HT // ischemia in lower body Arch N N Unknown
17 M 53 C AR, MR // CHF Ascending,
descending
N Y Right iliac artery,
celiac artery
18 M 43 C HT // NS Descending N Y RA
19 M 48 A HT, OCI // cardiac tamponade Descending N N Unknown
C, Chronic; HT, hypertension; CRF, chronic renal failure; s/p, status post; SMA, superior mesenteric artery; IMA, inferior mesenteric artery; A, acute; AR,
aortic regurgitation; NS, nothing special; AAA, abdominal aortic aneurysm; OCI, old cerebral infarction; LOC, loss of consciousness; AAE, annuluaortic
ectasia; CHF, congestive heart failure; RA, renal artery; HL, hyperlipidemia; IHD, ischemic heart disease; DM, diabetes mellitus; TAbA, thoracoabdominal
aneurysm; MR, mitral regurgitation.
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a length of 25 mm; Figure 2, B). Once the sheath is placed across
the entry in the descending aorta and the pushing rod is advanced
within the sheath, the stent graft is deployed by holding the rod in
position and withdrawing the sheath (Figure 2, B).
After the stent graft is deployed, a 14F Foley balloon is inserted
into the graft and inflated to confirm that the stent graft is fully
opened and not twisted or kinked. Blood is allowed to return from
the femoral arterial cannulation to expel the air and atheromatous
Figure 1. Stent graft and device for delivery. A and B, Complete form of stent graft composed of polyester graft and
a self-expandable Z-stent inserted into the distal portion of the graft. The stent was attached to the graft by a series
of interrupted 5-0 polypropylene sutures in the distal and proximal tips of the stent. C, A 30F catheter sheath and
pushing rod for the delivery of the stent graft. The catheter sheath was curved to correspond to the aortic arch.
Figure 2. Operative method. A, Type A aortic dissections in which the entry site is in the aortic arch, descending
aorta, or both. T, True lumen; F, false lumen; E, entry; RE, re-entry; CPB, cardiopulmonary bypass. B, The stent graft
is implanted into the descending aorta through surgically opened aortic arch by using the 30F catheter sheath (C).
C, Implanted stent graft (S-G) is sutured with the graft (4BG) that replaced the ascending aorta and neck vessels.
D, The entry site in the thoracic aorta is expected to close completely, and the false lumen is expected to
thrombose.
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plaque that might have been dislodged by the stent-graft implan-
tation. Subsequently, the proximal side of the stent graft is cut, its
edges are trued up with those of the transected aortic arch, and an
anastomotic stoma is created comprising the dissected aorta and
the Teflon strip reinforcement externally by using interrupted
mattress sutures (Figure 2, C). Finally, this anastomotic stoma is
sutured together with the distal portion of the 4-branched graft in
end-to-end anastomotic style.
After the air is eliminated from the femoral artery, the cardio-
pulmonary bypass is resumed, and surface and core rewarming are
initiated. During the rewarming, the right brachiocephalic artery is
reconstructed with one of the 4 branched grafts from the ascending
aorta (Figure 2, D).
Patient Follow-up
The patients were followed until March 2000 at the outpatient
clinic or through telephone contact. The follow-up was 100%
complete. The mean follow-up period was 2.4 1.6 years, and the
longest period was 5.5 years.
The effectiveness of stent-graft implantation in the acute phase
was estimated by the closure of the targeted entry site and clot
formation in the false lumen, as confirmed by means of transesoph-
ageal echocardiography on the day of the operation and enhanced
computed tomography at 2 weeks after the operation.
The effectiveness of stent-graft treatment in the chronic phase
was estimated from the change in diameter of the false lumen and
dissected aorta. All cases, except one acute-phase death, were
given prospective follow-up by means of enhanced computed
tomography at approximately 2 weeks (10-25 days after treat-
ment), 6 months (4-6 months after treatment), 1 year (10-14
months after treatment), and annually thereafter.
The diameters of the dissected aorta and false lumen were
measured at 3 predetermined levels in each computed tomographic
examination, including the preoperative computed tomographic
scan (Figure 3). The first measurement level was at the maximum
diameter of the descending aorta in the short axis, the second was
at the distal end of the stent graft, and the third was 50 mm distal
to the second measurement.
At each of these levels, the diameter of the dissected aorta was
measured in short-axis diameter, and the diameter of the false
lumen was measured as the distance between 2 parallel lines,
which were also parallel to the line connecting the 2 attachment
points of the intimal flap. The outer of the 2 parallel lines was
drawn through the outermost point of the false lumen, and the
inner line was drawn through the outermost point of the intimal
flap. These measurement methods were described in detail in a
previous study.18
Statistical Analysis
All continuous data are expressed as means  SD. Survival was
estimated by using the Kaplan-Meier method. Changes in the
diameters of the false lumen and dissected aorta between the
preoperative period and 6 months after the operation were ana-
lyzed with the paired t test. All calculations were performed with
a Statcel for Excel 98 on a Mac OS.
Results
Procedural Success
The stent-graft deployment within the true lumen of the
descending aorta from the transected aortic arch was tech-
nically successful in all 19 patients, and wide expansion of
Figure 3. Serial size changes of the diameter of the false lumen and the dissected aorta at the 3 measurement levels
before and after the operation in 17 patients. , Data of each case in which false lumen at the level is patent; ,
data of each case in which false lumen at the level is completely thrombosed; ˜, mean  SD.
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the stent was confirmed on the postoperative chest x-ray
films. Complete resection and sealing of the targeted entry
sites with our procedure were confirmed by means of intra-
operative color Doppler transesophageal echocardiography.
In one patient a postoperative ischemic event indicated a
new intimal tear formation 3 cm distal to the distal end of
the stent graft and subsequent narrowing of the true lumen.
Simultaneous with stent-graft implantation, 2 patients re-
ceived coronary artery bypass grafting, 1 received aortic
valve replacement, 3 received aortic root reconstruction,
and 1 received mitral annuloplasty. The operative time
ranged from 418 to 815 minutes (mean, 564  25 minutes
[9 hours and 24 minutes]), and the cardiopulmonary bypass
time ranged from 172 to 454 minutes (mean, 244  15
minutes [4 hours and 4 minutes]). Circulatory arrest in the
lower body (and selective cerebral perfusion) was required
for 18 to 70 minutes (mean, 42  3 minutes).
Postoperative computed tomographic scanning 1 to 4
weeks after the operation depicted complete thrombosis of
the aneurysm or the false lumen surrounding the stent graft
in all but 2 patients. In these 2 patients we had ligated the
left subclavian artery from inside the opened aortic arch and
observed retrograde leakage from the ligated left subclavian
artery to the false lumen. Even in these patients, complete
thrombosis of the false lumen was observed on the com-
puted tomographic scan after coil embolization to the root
of the left subclavian artery by using transbrachial catheter
intervention. In the patients with a preoperative narrowed
true lumen in the descending aorta, aortography and com-
puted tomographic scanning after stent-graft implantation
documented remarkable recovery of the true lumen to a
round shape and thrombosis of the false lumen. Bypass
grafts for the cephalic vessels were patent in all patients.
Early Mortality and Morbidity
The early results of total arch graft implantation with a stent
graft are shown in Table 2. One of the 19 patients died (9
days postoperatively), for an in-hospital mortality of 5.3%.
This operative death occurred in the patient with annuloaor-
tic ectasia who received aortic root reconstruction simulta-
neously with total arch graft implantation (patient 5). The
patient died as a result of postoperative stroke, low-output
syndrome, mediastinitis, and consequent multiorgan failure.
No other patient had a cerebrovascular accident. Tem-
porary paraparesis was noted in 2 patients, whose circula-
tory arrest times in the lower body were 30.5 and 34
minutes, and both patients almost fully recovered (ie, were
able to walk with a cane).
No pulmonary complication resulted, and there was one
case of postoperative hoarseness. The postoperative intuba-
TABLE 2. Result of 19 patients who received total arch-graft implantation with a stent graft for aortic dissection
Patients Combined operation Post-operative complication
Mortality in
hospital
(A  alive,
D  death)
Late
mortality
(A  alive,
D  death) Late morbidity
1 Suspension of AV  1 CABG () A A Removal of seroma
2 Reconstruction of coronary orfice () A A AMI, bedridden
3 AVR () A A ()
4 () () A D (AMI,
pneumonia)
AMI, pneumonia
5 Aortic root replace Mediastinitis, stroke D(MOF) ()
6 () () A A ()
7 Aortic root replace  1 CABG MNMS, ARF, probe laparotomy A A ()
8 Suspension of AV Reperfusion injury of left leg A A ()
9 () Temporary paraparesis A A Bedridden
10 Suspension of AV () A A TPEG
11 Suspension of AV () A A Hepatitis
12 Suspension of AV () A A Operation for rectal cancer
13 Suspension of AV Retrograde leakage from left SCA A A ()
14 () () A D (suicide) ()
15 Suspension of AV Mediastinitis A A ()
16 Bare stent placement in abdominal
aorta and iliac artery
() A A ()
17 Aortic root replace  MAP Hoarseness A A ()
18 () Retrograde leakage from left SCA A A ()
19 () Mediastinitis, ARF, temporary
paraparesis
A A ()
AV, Aortic valve; CABG, coronary artery bypass grafting; A, alive; AMI, acute myocardial infarction; AVR, aortic valve replacement; D, deceased; MOF,
multiorgan failure; MNMS, myonephropatic metabolic syndrome; ARF, acute renal failure; TPEG, transluminal-placed endovascular graft; SCA, subclavian
artery; MAP, mitral annuloplasty.
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tion period was 5 days or less in 15 patients and more than
5 days in 4 patients, and no patients needed tracheostomy.
Two (10.5%) patients required temporary hemodialysis. In
one patient (patient 7) hemodialysis was performed for
reperfusion injuries in the leg and intestine that were related
to a preoperative ischemic condition. This patient also re-
quired a laparotomy for investigation, but no resection of
the intestine was necessary. The second patient for whom
hemodialysis was administered (patient 19) had a postop-
erative ischemic event in the visceral artery and both legs.
This postoperative ischemia was successfully treated by
means of bare stent implantation into the narrowed true
lumen of the thoracoabdominal aorta on the second postop-
erative day. There were 3 cases of mediastinitis, all of which
were treated with mediastinal washing, irrigation, and drain-
age. In 2 of the patients, we were able to perform omental
flap implantation after thorough washing and drainage, and
the third patient was the only case of death in this series
(patient 5). The early results of total arch graft implantation
with the stent graft are shown in Table 2.
Late Mortality and Morbidity
The survivals for all patients 1 and 3 years postoperatively
were 89.5% and 82.6%, respectively. There were 2 late
deaths: One patient committed suicide 3 months after the
operation, and the other patient died of cardiac and pulmo-
nary complications.
Two nonfatal events related to the operation were noted
in the chronic phase. In one patient a reoperation was
required for seroma in the mediastinum caused by the
bypass graft (polytetrafluoroethylene graft) to the cervical
branch. The other patient required an additional stent-graft
implantation from the femoral artery (transluminal-placed
endovascular graft) 1 year after the initial operation to close
an intrathoracic residual entry site that was not detected
before the initial operation. This patient (patient 10) is the
only one who needed reoperation related to dissection of the
aorta. The late mortality and morbidity of all patients are
shown in Table 2.
Outcome for the Dissected Aorta and False Lumen
With the aid of 46 examinations, we observed serial size
changes in the false lumen and the dissected aorta in 17
patients at the first 6 months after the stent-graft placement
and thereafter. Computed tomographic examinations were
performed according to schedule in 15 patients, but fol-
low-up computed tomographic examinations were discon-
tinued in 2 patients at 6 months and 2 years because aging
kept them from unassisted walking and they could not come
to our outpatient clinic for follow-up. At the level of the end
of the stent graft, the data on 2 patients were omitted from
serial follow-up data because in both patients there was no
aortic dissection and false lumen at that level through the
entire period. At the level 5 cm distal to the stent graft, the
data on 5 patients were omitted for the same reason.
Postoperative computed tomographic examinations at 6
months showed that all 17 false lumens at the level of
maximum aortic diameter had clotted, that the diameter of
the false lumen at that level had been reduced by more than
50% in 16 (94.1%) patients, and that the aortic diameter had
been reduced by more than 20% in 11 (64.7%) patients.
Two more patients had a greater than 20% reduction of the
aortic diameter after 6 months. The mean diameter of the
false lumen at 6 months was 4.1  6.4 mm (vs 22.1  7.9
mm preoperatively), the mean aortic diameter was 32.4 
8.9 mm (vs 42.1  6.7 mm preoperatively), and both were
significantly decreased compared with preoperative diame-
ters. At the same level, the mean diameters of the false
lumen and the dissected aorta were 2.1  3.4 and 30.5 
6.2 mm, respectively, at 1 year and 3.0 4.8 and 31.0 7.2
mm, respectively, at 2 years. The changes in the diameter of
the false lumen and the aorta are shown in Figure 3. In the
follow-up period no patient had an enlargement of the aortic
diameter greater than 20% from the preoperative state at this
level.
At the level of the end of the stent graft, the false lumen
was absent in 2 patients and already clotted at the initial
(preoperative) computed tomographic examination in 5 oth-
ers. Of the 10 patent false lumina at this level, 8 (80%) were
completely clotted at 6 months. There was a residual patent
false lumen at this level in one patient (patient 7) as a result
of back flow from an abdominal re-entry site near the celiac
artery. The other instance of a patent false lumen resulted
from flow from an intrathoracic residual entry site that could
not be detected at the initial operation (patient 10). In one
case of a preoperatively clotted false lumen, a postopera-
tively reopened false lumen with a postoperative new entry
site was noted as the result of a postoperative ischemic
event in the lower body (patient 19).
At this level, the false lumen had been reduced by more
than 50% from the preoperative diameter in 9 (60%) of 15
patients at 6 months, and the aortic diameter had been
reduced by more than 20% in 6 (40%) of 15 patients. After
6 months, the aortic diameter showed this amount of reduc-
tion in 2 other patients. The mean diameter of the false
lumen at 6 months was 6.6  8.0 mm (vs 15.5  8.1 mm
preoperatively), and the mean aortic diameter was 31.4 
8.5 mm (vs 34.3  4.7 mm preoperatively); both were
significantly decreased compared with preoperative diame-
ters. At the same level, mean diameters of the false lumen
and the dissected aorta at 1 year were 3.2  5.9 mm and
28.4  8.0 mm, respectively, and the respective mean
diameters were 4.3  4.8 mm and 28.0  7.2 mm, respec-
tively, at 2 years. In the follow-up period, 2 (13.3%) patients
had greater than 20% enlargement of the aortic diameter
compared with its preoperative state at this level; in both
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patients (patients 7 and 19) the computed tomographic scans
showed a patent false lumen 6 months after the operation.
There were no cases in which the aortic diameter was larger
than 60 mm (ie, should have been be considered for reop-
eration).
The following measurements all pertain to the level 5 cm
distal to the stent graft. Among 9 patent false lumina (a false
lumen was absent in 5 patients and already clotted at the
initial computed tomographic examination in 3 patients), 3
(33.3%) patients had total clotting 6 months after the oper-
ation. A greater than 50% reduction of the false lumen
diameter compared with the preoperative diameter was ob-
served in 6 (50%) of the 12 patients, and greater than 20%
reduction of the aortic diameter was observed in 2 (16.7%)
of the 12 patients 6 months after the operation. The mean
diameter of the false lumen 6 months after the operation was
11.4  9.3 mm (vs 17.1  7.3 mm preoperatively), a
significant decrease compared with preoperative diameter,
and the mean aortic diameter was 30.1 5.9 mm (vs 30.8
3.4 mm preoperatively). The mean diameters of the false
lumen and the dissected aorta at 1 year were 7.8  10.1 and
27.3  6.1 mm, respectively, and those at 2 years were
16.0  14.5 and 33.0  8.7 mm, respectively. In the
follow-up period, 3 (25%) patients had greater than 20%
enlargement of the aortic diameter relative to the preoper-
ative state. Two of them were the same patients (patients 7
and 19) with enlargement at the level of the end of stent
graft; the other (patient 8) had the case of suspected Marfan
syndrome, in which there was a large re-entry site near the
celiac artery. There were no cases in which the aortic
diameter was larger than 60 mm (ie, should have been
considered for reoperation).
Discussion
The purpose of our total arch graft implantation method is to
obtain complete closure of intrathoracic entry sites for type
A aortic dissection with less invasiveness than with the
conventional total arch graft implantation. Open-style stent-
graft placement provides distal anastomotic fixation by us-
ing a self-expandable stent, obviating the need for a distal
anastomotic suture. Unlike the conventional total arch graft
implantation, which requires dissection, incision, and su-
tures on both the proximal and distal ends, our open-style
stent-graft implantation requires these troublesome manip-
ulations only on the proximal anastomotic side. This
method also provides a high probability of clotting and
shrinkage of the false lumen with a result of complete
entry-site closure and maintenance of a wide true lumen,
secured by the expansile force of the stent graft, that was
often narrowed preoperatively by the dilated false lumen.
Hence our new graft-implanting method with open-style
stent-graft placement for type A aortic dissection might well
provide better results in the acute phase and the subsequent
posttreatment chronic phase.
The surgical mortality for graft replacement of the as-
cending aorta for type A dissection has been reported as
ranging from 9% to 21.8%,5,11,19 and that of total arch graft
replacement has been reported as ranging from 17% to
55%.19-27 Surgical mortality in our series was 5.3%. The
rate of cerebral, respiratory, and renal complications has
been reported as 2.5% to 11.8%, 6% to 19%, and 5% to
12.2%, respectively, in the conventional surgical treat-
ment.3,5-7,19 In our series the rates of cerebral and renal
complications (5.3% and 10.6%, respectively) were compa-
rable with those of conventional treatment. The rate for
respiratory complication in our series (0%, no patient
needed a tracheostomy) was much lower than that seen in
previous reports because our technique does not require us
to touch the recurrent nerve and phrenic nerve or to open the
thorax and compress the left lung. Also, even in 3 patients
(patients 7, 8, and 16) with preoperative critical ischemia of
the leg or organs, the patients recovered after the initial
operation. (Postoperatively, however, a new entry site was
observed in a different patient [patient 19], followed by
ischemia in the visceral organs and both legs.) These good
results in the acute phase seemed to be associated with the
stent-graft procedure’s reduced invasiveness, complete en-
try-site closure, and secure perfusion to the lower body.
The ordinary motivation for total arch graft replacement
for type A dissection is to prevent enlargement of the
residual dissection. There are few reports of meticulous
follow-up of residual dissection after the ascending opera-
tion for type A dissection. The reported rate for enlargement
of residual dissection was 17% at 3 years from the initial
operation13 and 37% at 5 years.15 Enlargement after the
initial operation was enhanced in patients who had a patent
residual false lumen, were young, or had Marfan syn-
drome.11,12,14-16 The rate of patent residual false lumen after
the ascending operation for type A dissection was 47% to
83%.7,14,15,28,29 Two causes have been proposed to account
for these high rates: a residual entry site in the arch de-
scending aorta or neck vessels and leakage from the distal
anastomosis in ascending graft replacement. On the other
hand, the dissected aorta in type B dissection is destined to
enlarge if its maximum diameter is greater than 40 mm in
the acute phase.30 To reduce the rate of enlargement of
residual dissection after the operation for type A dissection,
we should completely separate the entry site from the false
lumen, especially in the patient who is young, has Marfan
syndrome, or has a maximum aortic diameter of greater than
40 mm in residual dissected aorta and not create a new entry
site in the distal anastomotic portion. To meet these require-
ments, we performed total arch graft implantation with a
stent graft on targeted patients who were highly likely to
have aortic enlargement of residual dissection if treated only
with graft replacement of the ascending aorta (ie, those who
were young, had Marfan syndrome, or had a maximum
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dissected aorta of 40 mm and an entry site in the arch-
descending aorta or had neck vessel dissection). In our
surgical treatment with the stent graft, we obtained clotting
of the residual dissection in 80%; enlargement of the resid-
ual dissection was observed in only 2 (13.3%) patients at the
level of the end of the stent graft, with a mean follow-up
period of 2.4 years. Additional aortic treatment related to
residual dissection was required in only one (5.9%) patient.
The number of data on residual dissection was limited (10
patients for the level of the end of the stent graft, 9 for 5 cm
distal to the stent graft), and the follow-up period was short.
Nevertheless, these data concerning dilatation and addi-
tional treatment in the chronic phase were satisfactory
enough, considering that the targeted patients in our series
were highly likely to have enlargement of residual dissec-
tion if they had received the conventional surgical treat-
ment. Furthermore, this total arch graft–implanting method
has an advantage, even in the patient who postoperatively
has residual dissection in the descending aorta, because the
additional transcatheter stent-graft placement can be easily
implanted through the femoral artery after achievement of
local anesthesia.18,31-33
In our experience with this series, some unpleasant com-
plications were observed in exchange for satisfactory fate of
the residual false lumen. There were 2 cases of paraparesis
(which is a seldom-seen complication after conventional
treatment); however, they were temporary. In these patients
the end of the implanted stent graft was placed at the level
of T6, and circulatory arrest of the lower body was accom-
plished within 40 minutes with hypothermia. The hypothe-
sized reasons for this complication are air or thromboem-
bolism caused by insertion of the stent graft or complete
clotting and stoppage of blood flow to the Adamkiewicz
artery that branched from the false lumen.34 Meticulous air
and thrombus elimination during the stent-graft insertion,
along with perioperative spinal protection, might be needed
to protect against this terrible complication. Also, the rela-
tively high incidence of mediastinitis (3/19 patients) might
be related to the long operative time associated with this
operation. Refinements in procedure and greater facility
with this new operation should reduce or eliminate these
troublesome complications.
With our approach, there might be some risk of intimal
trauma because of the continuous compression of the stent
graft on the dissected and weakened intimal wall, but in the
small number of recent reports of stent-graft placement for
acute aortic dissection, there was no report about this anx-
iety.18,32,33 In postmortem examinations of our cases of
surgical death, the following were observed: clotting of the
false lumen, slight hyalinosis of intimal wall, and no thin-
ning of the intimal wall. In fact, stent-graft implantation for
acute aortic dissection was associated with quick clot for-
mation and shrinkage of the false lumen after stent-graft
implantation, and this healing process might promote good
blood supply to the intimal wall from the adventitia and
subsequently play a role in preventing new trauma to the
intimal wall. In any case the proper size adjustment of the
stent graft and the device selected might be key to prevent-
ing trauma to intima that is dissected and might be fragile.
In summary, our preliminary experience with the total
arch graft implantation with a stent graft for the selected
patient with type A aortic dissection suggests that this new
procedure might provide better surgical results in the acute
and chronic phase, especially with regard to the fate of the
false lumen, than does conventional treatment.
We thank Yumi Hamada for secretarial assistance in preparing
this manuscript and A1 Averbach for editing the manuscript.
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